Skip to content

Clinical trials

Active, not recruiting Endometrial Neoplasms trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Endometrial Neoplasms Status: Active, not recruiting Country / region: United States Clear all

80 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20071
20081
20101
20111
20141
20152
20162
20173
20182
20199
202012
202112
20226
202314
20247
20254
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Active, not recruiting80

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)8
M.D. Anderson Cancer Center7
Memorial Sloan Kettering Cancer Center4
Eli Lilly and Company3
Merck Sharp & Dohme LLC3
University of Oklahoma3
AstraZeneca2
Dana-Farber Cancer Institute2
GlaxoSmithKline2
Mayo Clinic2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Endometrial Neoplasms80
Ovarian Neoplasms32
Uterine Cervical Neoplasms18
Breast Neoplasms17
Colorectal Neoplasms16
Carcinoma, Non-Small-Cell Lung14
Prostatic Neoplasms14
Neoplasms12
Stomach Neoplasms11
Colonic Neoplasms10

Trials

Showing 1 to 25 of 80. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.